PMID- 26033902
OWN - NLM
STAT- MEDLINE
DCOM- 20150810
LR  - 20181113
IS  - 1535-5667 (Electronic)
IS  - 0161-5505 (Print)
IS  - 0161-5505 (Linking)
VI  - 56 Suppl 4
IP  - 0 4
DP  - 2015 Jun
TI  - Role of Cardiac MR Imaging in Cardiomyopathies.
PG  - 39S-45S
LID - 10.2967/jnumed.114.142729 [doi]
AB  - Cardiac MR imaging has made major inroads in the new millennium in the diagnosis 
      and assessment of prognosis for patients with cardiomyopathies. Imaging of left 
      and right ventricular structure and function and tissue characterization with 
      late gadolinium enhancement (LGE) as well as T1 and T2 mapping enable accurate 
      diagnosis of the underlying etiology. In the setting of coronary artery disease, 
      either transmurality of LGE or contractile reserve in response to dobutamine can 
      assess the likelihood of recovery of function after revascularization. The 
      presence of scar reduces the likelihood of a response to medical therapy and to 
      cardiac resynchronization therapy in heart failure. The presence and extent of 
      LGE relate to overall cardiovascular outcome in cardiomyopathies. A major role 
      for cardiac MR imaging in cardiomyopathies is to identify myocardial scar for 
      diagnostic and prognostic purposes.
CI  - (c) 2015 by the Society of Nuclear Medicine and Molecular Imaging, Inc.
FAU - Kramer, Christopher M
AU  - Kramer CM
AD  - Cardiovascular Imaging Center, University of Virginia Health System, 
      Charlottesville, Virginia ckramer@virginia.edu.
LA  - eng
GR  - R01 HL075792/HL/NHLBI NIH HHS/United States
GR  - U01 HL117006/HL/NHLBI NIH HHS/United States
GR  - U01HL117006-01A1/HL/NHLBI NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
PL  - United States
TA  - J Nucl Med
JT  - Journal of nuclear medicine : official publication, Society of Nuclear Medicine
JID - 0217410
RN  - 0 (Contrast Media)
RN  - AU0V1LM3JT (Gadolinium)
SB  - IM
MH  - Amyloidosis/pathology
MH  - Cardiac Resynchronization Therapy
MH  - Cardiomyopathies/*diagnosis/*pathology
MH  - Cicatrix/pathology
MH  - Contrast Media
MH  - Gadolinium
MH  - Heart/*physiopathology
MH  - Heart Failure/pathology
MH  - Humans
MH  - *Magnetic Resonance Imaging
MH  - Myocardial Contraction
MH  - Myocardial Ischemia/pathology
MH  - Myocardial Revascularization
MH  - Myocarditis/pathology
MH  - Myocardium/*pathology
MH  - Prognosis
MH  - Sarcoidosis/pathology
PMC - PMC4465292
MID - NIHMS697519
OTO - NOTNLM
OT  - cardiac MR imaging
OT  - coronary artery disease
OT  - infiltrative cardiomyopathy
OT  - ischemic cardiomyopathy
OT  - late gadolinium enhancement
OT  - nonischemic cardiomyopathy
EDAT- 2015/06/03 06:00
MHDA- 2015/08/11 06:00
PMCR- 2016/06/01
CRDT- 2015/06/03 06:00
PHST- 2015/06/03 06:00 [entrez]
PHST- 2015/06/03 06:00 [pubmed]
PHST- 2015/08/11 06:00 [medline]
PHST- 2016/06/01 00:00 [pmc-release]
AID - 56/Supplement_4/39S [pii]
AID - 10.2967/jnumed.114.142729 [doi]
PST - ppublish
SO  - J Nucl Med. 2015 Jun;56 Suppl 4(0 4):39S-45S. doi: 10.2967/jnumed.114.142729.